Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing based on Patient Clinical Outcomes

Trial Identifier:	D961HL00020
Sponsor:	AstraZeneca
NCTID::	NCT02477475
Start Date:	July 2015
Primary Completion Date:	February 2017
Study Completion Date:	February 2017
Condition:	Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Fukui, Japan
Japan	Kochi, Japan
Japan	Okinawa, Japan
Japan	Yamanashi, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.